Moreover, RasGRP3 mutation led to the promotion of cell proliferation, migration, and invasion, whereas NIS and TSHR expression and RAI uptake declined through AKT activation in thyroid cancer cells. The gene discussed is RASGRP3; the disease is thyroid cancer.